Further, a recent complementary study by Kawagishi et al. suggested a p53-independent role for ARF in suppressing tumor angiogenesis via post-transcriptional control of VEGF-A expression [30]; however, in the RIP-Tag2 PNET tumors, VEGF protein levels were not significantly altered by loss of Arf. This evidence concerns the gene TP53 and neoplasm.